Healthcare provider profile · identity verified

Jim Wang, DO

Family Practice · PAHRUMP, NV · NPI 1962614388

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	675	236
Levothyroxine Sodium	Levothyroxine Sodium	462	155
Lisinopril	Lisinopril	413	144
Omeprazole	Omeprazole	323	114
Albuterol Sulfate Hfa	Albuterol Sulfate	301	85
Metformin Hcl	Metformin Hcl	301	105
Amlodipine Besylate	Amlodipine Besylate	292	113
Losartan Potassium	Losartan Potassium	245	101
Gabapentin	Gabapentin	201	66
Trazodone Hcl	Trazodone Hcl	193	70
Tamsulosin Hcl	Tamsulosin Hcl	189	70
Hydrochlorothiazide	Hydrochlorothiazide	181	68
Duloxetine Hcl	Duloxetine Hcl	171	62
Metoprolol Tartrate	Metoprolol Tartrate	170	56
Fluticasone Propionate	Fluticasone Propionate	168	69
Simvastatin	Simvastatin	158	58
Furosemide	Furosemide	148	55
Montelukast Sodium	Montelukast Sodium	148	49
Diclofenac Sodium	Diclofenac Sodium	140	53
Rosuvastatin Calcium	Rosuvastatin Calcium	139	63
Terazosin Hcl	Terazosin Hcl	136	42
Glipizide	Glipizide	130	41
Citalopram Hbr	Citalopram Hydrobromide	115	45
Baclofen	Baclofen	107	45
Ibuprofen	Ibuprofen	104	37
Pantoprazole Sodium	Pantoprazole Sodium	96	33
Carvedilol	Carvedilol	95	34
Metoprolol Succinate	Metoprolol Succinate	86	32
Alendronate Sodium	Alendronate Sodium	82	26
Clopidogrel	Clopidogrel Bisulfate	77	30
Eliquis	Apixaban	73	20
Azithromycin	Azithromycin	69	65
Pravastatin Sodium	Pravastatin Sodium	65	26
Oxybutynin Chloride	Oxybutynin Chloride	63	22
Potassium Chloride	Potassium Chloride	63	24
Chlorthalidone	Chlorthalidone	62	19
Pregabalin	Pregabalin	61	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	57	11
Sertraline Hcl	Sertraline Hcl	56	18
Allopurinol	Allopurinol	53	19
Atenolol	Atenolol	53	18
Symbicort	Budesonide/Formoterol Fumarate	53	suppressed
Famotidine	Famotidine	50	19
Hydroxyzine Hcl	Hydroxyzine Hcl	49	17
Warfarin Sodium	Warfarin Sodium	49	17
Finasteride	Finasteride	47	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	46	21
Lovastatin	Lovastatin	46	14
Buspirone Hcl	Buspirone Hcl	45	17
Meloxicam	Meloxicam	45	18
Spironolactone	Spironolactone	45	14
Paroxetine Hcl	Paroxetine Hcl	43	14
Pioglitazone Hcl	Pioglitazone Hcl	43	13
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	42	31
Sildenafil Citrate	Sildenafil Citrate	40	13
Donepezil Hcl	Donepezil Hcl	38	16
Ezetimibe	Ezetimibe	38	13
Tizanidine Hcl	Tizanidine Hcl	38	14
Xarelto	Rivaroxaban	37	12
Fluoxetine Hcl	Fluoxetine Hcl	36	suppressed
Nitroglycerin	Nitroglycerin	36	suppressed
Glipizide Er	Glipizide	35	11
Sumatriptan Succinate	Sumatriptan Succinate	35	suppressed
Benazepril Hcl	Benazepril Hcl	34	12
Methylprednisolone	Methylprednisolone	34	32
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	13
Naproxen	Naproxen	30	16
Wixela Inhub	Fluticasone Propion/Salmeterol	28	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	26	suppressed
Fenofibrate	Fenofibrate	26	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	26	24
Celecoxib	Celecoxib	25	suppressed
Meclizine Hcl	Meclizine Hcl	25	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	suppressed
Acyclovir	Acyclovir	23	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	11
Spiriva Handihaler	Tiotropium Bromide	23	suppressed
Loperamide	Loperamide Hcl	22	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Cephalexin	Cephalexin	21	21
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	11
Glimepiride	Glimepiride	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Amiodarone Hcl	Amiodarone Hcl	19	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	19	suppressed
Nystatin	Nystatin	19	suppressed
Ozempic	Semaglutide	19	suppressed
Tramadol Hcl	Tramadol Hcl	19	suppressed
Epinephrine	Epinephrine	18	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	18	suppressed
Rexulti	Brexpiprazole	18	suppressed
Metformin Hcl Er	Metformin Hcl	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Folic Acid	Folic Acid	16	suppressed
Jardiance	Empagliflozin	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Prednisone	Prednisone	15	11
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Elmiron	Pentosan Polysulfate Sodium	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Testosterone Cypionate	Testosterone Cypionate	14	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Colchicine	Colchicine	12	suppressed
Temazepam	Temazepam	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Primidone	Primidone	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error